Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Jourik A. Gietema

1-50 of 195 results

View this query on the Wikidata Query Service
Metformin: taking away the candy for cancer?

scientific article published on 23 July 2010
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer

scientific article
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer

scientific article published in October 2007
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer

scientific article
A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours

scientific article published on 15 January 2008
Prognostic versus predictive value of biomarkers in oncology.

scientific article published on 07 April 2008
Cardiovascular toxicity caused by cancer treatment: strategies for early detection

scientific article published on April 2009
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

scientific article published in May 2006
Testicular cancer survivorship: research strategies and recommendations

scientific article
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.

scientific article published on 14 November 2012
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up

scientific article published on 24 September 2012
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

scientific article published on 28 February 2005
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.

scientific article
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer.

scientific article published on September 2010
The metabolic syndrome in cancer survivors.

scientific article published on February 2010
Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer

scientific article
The clinical trail of TRAIL.

scientific article published on August 2006
Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies

scientific article
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.

scientific article published on 24 August 2007
Genetic polymorphisms associated with a prolonged progression-free survival in patients with metastatic renal cell cancer treated with sunitinib

scientific article published on 19 November 2010
Detection of anthracycline-induced cardiotoxicity.

scientific article
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake

scientific article published on 11 April 2013
VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment

scientific article published on 17 November 2010
Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway.

scientific article
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.

scientific article
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer

scientific article published on October 2008
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer

scientific article published on 01 March 2000
Angiotensin II-Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer: A Randomized Clinical Trial.

scientific article published on 23 June 2016
Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures

scientific article published on 17 January 2017
Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer.

scientific article published in March 2004
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.

scientific article published in May 2004
Translating TRAIL-receptor targeting agents to the clinic.

scientific article published on 21 April 2012
89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

scientific article published on 26 November 2018
Optimisation of circulating biomarkers of cell death for routine clinical use.

scientific article published on 27 February 2008
Antibody positron emission tomography imaging in anticancer drug development.

scientific article published on 16 March 2015
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy

scientific article published in December 2009
The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures

scientific article
Early development of the metabolic syndrome after chemotherapy for testicular cancer.

scientific article published on 6 November 2012
Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer

scientific article published in May 1992
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.

scientific article published on 4 December 2014
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer

scientific article published on 01 August 2005
Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study

scientific article
Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients

scientific article
TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET.

scientific article
A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors

scientific article published on 25 May 2006
Phase I study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with 5-fluorouracil and leucovorin: a safe combination.

scientific article published on 10 January 2006
Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours

scientific article
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment.

scientific article
In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo.

scientific article published on December 2005
Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutrition

scientific article published on 01 November 1989

Paulina is supported by:

About Paulina

Help